PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Yup running conservative numbers out for just OA the numbers are...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Yup running conservative numbers out for just OA the numbers are frightning. Say we only get a 20% royalty = $3b less costs 50% = $1.5b = about $6.00 earnings per share. Then add the bio PE multiple of 40 times.... = $240 per share on conservative estimates......
    Thats why Mozz wets his pants everytime he speaks about PAR.. But here we sit at $2.41 on Phase 3 - Ind Approval ... What are we missing ? Anybody?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.